Genetics
Ocular gene therapy: The next generation
Emerging viral and synthetic vectors along with newer delivery platforms are poised to broaden genetic treatments in retina.
Gene therapy and editing for the retina: A primer
A look at advances in gene replacement therapy, gene delivery and CRISPR technology.
First results of gene and cell therapies for nAMD, RP, plus ...
Findings on predictors of endophthalmitis, widefield OCT-A vs. FA and microsecond pulsing laser make five worthy takeaways.
IOP and anti-VEGF drugs: What we know so far
Chronic changes in intraocular pressure may be dependent on the anti-VEGF drug used. A look at emerging research on physiology and the role of genetics.
Current Issue
Continuing Medical Education
Additional Publications
Tuesday, October 8, 2024 | Learn More About Stargardt Disease
Location: Webinar
Time: 7:00 PM ET
Time: 7:00 PM ET
Speaker: Lejla Vajzovic, MD, FASRS
Sponsored by Alkeus Pharmaceuticals, Inc.
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
